Antagonist angiotenzin II receptora (Serbo-Croatian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Antagonist angiotenzin II receptora" in Serbo-Croatian language version.

refsWebsite

Global rank Serbo-Croatian rank

6doi.org

2^nd place

6nih.gov

4^th place

3^rd place

1archive.org

6^th place

5^th place

1web.archive.org

1^st place

1bentham-direct.org

low place

5,831^st place

archive.org

Gales BJ, Bailey EK, Reed AN, Gales MA (2010). „Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for the prevention of migraines”. Ann Pharmacother 44 (2): 360–6. DOI:10.1345/aph.1M312. PMID 20086184.

bentham-direct.org

Daskalopoulou SS, Tzovaras V, Mikhailidis DP, Elisaf M (2005). „Effect on serum uric acid levels of drugs prescribed for indications other than treating hyperuricaemia”. Curr. Pharm. Des. 11 (32): 4161–75. DOI:10.2174/138161205774913309. PMID 16375738. Arhivirano iz originala na datum 2009-05-24. Pristupljeno 2021-08-15.

doi.org

dx.doi.org

Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G. (2003). „Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial”. JAMA 1 (289 Pt 1): 65–9. DOI:10.1001/jama.289.1.65. PMID 12503978.
Cernes R, Mashavi M, Zimlichman R (2011). „Differential clinical profile of candesartan compared to other angiotensin receptor blockers”. Vasc Health Risk Manag 7: 749–59. DOI:10.2147/VHRM.S22591. PMC 3253768. PMID 22241949.
Gales BJ, Bailey EK, Reed AN, Gales MA (2010). „Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for the prevention of migraines”. Ann Pharmacother 44 (2): 360–6. DOI:10.1345/aph.1M312. PMID 20086184.
Kassler-Taub K, Littlejohn T, Elliott W, Ruddy T, Adler E. (1998). „Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study Investigators”. Am J Hypertens 11 (4 Pt 1): 445–53. DOI:10.1016/S0895-7061(97)00491-3. PMID 9607383.
Dang A, Zhang Y, Liu G, Chen G, Song W, Wang B (January 2006). „Effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia in Chinese population”. J Hum Hypertens 20 (1): 45–50. DOI:10.1038/sj.jhh.1001941. PMID 16281062.
Daskalopoulou SS, Tzovaras V, Mikhailidis DP, Elisaf M (2005). „Effect on serum uric acid levels of drugs prescribed for indications other than treating hyperuricaemia”. Curr. Pharm. Des. 11 (32): 4161–75. DOI:10.2174/138161205774913309. PMID 16375738. Arhivirano iz originala na datum 2009-05-24. Pristupljeno 2021-08-15.

nih.gov

ncbi.nlm.nih.gov

Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G. (2003). „Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial”. JAMA 1 (289 Pt 1): 65–9. DOI:10.1001/jama.289.1.65. PMID 12503978.
Cernes R, Mashavi M, Zimlichman R (2011). „Differential clinical profile of candesartan compared to other angiotensin receptor blockers”. Vasc Health Risk Manag 7: 749–59. DOI:10.2147/VHRM.S22591. PMC 3253768. PMID 22241949.
Gales BJ, Bailey EK, Reed AN, Gales MA (2010). „Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for the prevention of migraines”. Ann Pharmacother 44 (2): 360–6. DOI:10.1345/aph.1M312. PMID 20086184.
Kassler-Taub K, Littlejohn T, Elliott W, Ruddy T, Adler E. (1998). „Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study Investigators”. Am J Hypertens 11 (4 Pt 1): 445–53. DOI:10.1016/S0895-7061(97)00491-3. PMID 9607383.
Dang A, Zhang Y, Liu G, Chen G, Song W, Wang B (January 2006). „Effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia in Chinese population”. J Hum Hypertens 20 (1): 45–50. DOI:10.1038/sj.jhh.1001941. PMID 16281062.
Daskalopoulou SS, Tzovaras V, Mikhailidis DP, Elisaf M (2005). „Effect on serum uric acid levels of drugs prescribed for indications other than treating hyperuricaemia”. Curr. Pharm. Des. 11 (32): 4161–75. DOI:10.2174/138161205774913309. PMID 16375738. Arhivirano iz originala na datum 2009-05-24. Pristupljeno 2021-08-15.

web.archive.org

Daskalopoulou SS, Tzovaras V, Mikhailidis DP, Elisaf M (2005). „Effect on serum uric acid levels of drugs prescribed for indications other than treating hyperuricaemia”. Curr. Pharm. Des. 11 (32): 4161–75. DOI:10.2174/138161205774913309. PMID 16375738. Arhivirano iz originala na datum 2009-05-24. Pristupljeno 2021-08-15.